nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA6—saliva—attention deficit hyperactivity disorder	0.0249	0.053	CbGeAlD
Topiramate—GRIK4—forebrain—attention deficit hyperactivity disorder	0.0172	0.0367	CbGeAlD
Topiramate—GRIA4—forebrain—attention deficit hyperactivity disorder	0.0136	0.029	CbGeAlD
Topiramate—GRIK3—forebrain—attention deficit hyperactivity disorder	0.0126	0.0268	CbGeAlD
Topiramate—GRIK5—forebrain—attention deficit hyperactivity disorder	0.0126	0.0268	CbGeAlD
Topiramate—GRIK1—forebrain—attention deficit hyperactivity disorder	0.0119	0.0255	CbGeAlD
Topiramate—GRIA3—forebrain—attention deficit hyperactivity disorder	0.0111	0.0237	CbGeAlD
Topiramate—GRIK4—nervous system—attention deficit hyperactivity disorder	0.00935	0.0199	CbGeAlD
Topiramate—GRIK4—central nervous system—attention deficit hyperactivity disorder	0.00901	0.0192	CbGeAlD
Topiramate—GRIK4—cerebellum—attention deficit hyperactivity disorder	0.0088	0.0188	CbGeAlD
Topiramate—GRIK3—midbrain—attention deficit hyperactivity disorder	0.0083	0.0177	CbGeAlD
Topiramate—GRIK5—midbrain—attention deficit hyperactivity disorder	0.0083	0.0177	CbGeAlD
Topiramate—GRIK1—midbrain—attention deficit hyperactivity disorder	0.00789	0.0168	CbGeAlD
Topiramate—GRIA4—nervous system—attention deficit hyperactivity disorder	0.00739	0.0158	CbGeAlD
Topiramate—GRIA3—midbrain—attention deficit hyperactivity disorder	0.00733	0.0156	CbGeAlD
Topiramate—GRIK4—brain—attention deficit hyperactivity disorder	0.00715	0.0152	CbGeAlD
Topiramate—GRIA4—central nervous system—attention deficit hyperactivity disorder	0.00712	0.0152	CbGeAlD
Topiramate—GRIA4—cerebellum—attention deficit hyperactivity disorder	0.00696	0.0148	CbGeAlD
Topiramate—GRIK5—nervous system—attention deficit hyperactivity disorder	0.00682	0.0145	CbGeAlD
Topiramate—GRIK3—nervous system—attention deficit hyperactivity disorder	0.00682	0.0145	CbGeAlD
Topiramate—GRIK3—central nervous system—attention deficit hyperactivity disorder	0.00657	0.014	CbGeAlD
Topiramate—GRIK5—central nervous system—attention deficit hyperactivity disorder	0.00657	0.014	CbGeAlD
Topiramate—GRIK1—nervous system—attention deficit hyperactivity disorder	0.00648	0.0138	CbGeAlD
Topiramate—GRIK3—cerebellum—attention deficit hyperactivity disorder	0.00642	0.0137	CbGeAlD
Topiramate—GRIK5—cerebellum—attention deficit hyperactivity disorder	0.00642	0.0137	CbGeAlD
Topiramate—GRIK1—central nervous system—attention deficit hyperactivity disorder	0.00624	0.0133	CbGeAlD
Topiramate—GRIK1—cerebellum—attention deficit hyperactivity disorder	0.0061	0.013	CbGeAlD
Topiramate—GRIA3—nervous system—attention deficit hyperactivity disorder	0.00603	0.0128	CbGeAlD
Topiramate—GRIA1—forebrain—attention deficit hyperactivity disorder	0.00593	0.0126	CbGeAlD
Topiramate—GRIA3—central nervous system—attention deficit hyperactivity disorder	0.0058	0.0124	CbGeAlD
Topiramate—GRIA3—cerebellum—attention deficit hyperactivity disorder	0.00567	0.0121	CbGeAlD
Topiramate—GRIA4—brain—attention deficit hyperactivity disorder	0.00565	0.012	CbGeAlD
Topiramate—GRIK5—brain—attention deficit hyperactivity disorder	0.00522	0.0111	CbGeAlD
Topiramate—GRIK3—brain—attention deficit hyperactivity disorder	0.00522	0.0111	CbGeAlD
Topiramate—GRIK1—brain—attention deficit hyperactivity disorder	0.00496	0.0106	CbGeAlD
Topiramate—GRIA2—forebrain—attention deficit hyperactivity disorder	0.00471	0.01	CbGeAlD
Topiramate—GRIA3—brain—attention deficit hyperactivity disorder	0.00461	0.00982	CbGeAlD
Topiramate—SCN1A—forebrain—attention deficit hyperactivity disorder	0.0043	0.00916	CbGeAlD
Topiramate—GRIK2—forebrain—attention deficit hyperactivity disorder	0.00426	0.00907	CbGeAlD
Topiramate—CA7—midbrain—attention deficit hyperactivity disorder	0.00404	0.00862	CbGeAlD
Topiramate—CA12—forebrain—attention deficit hyperactivity disorder	0.00398	0.00848	CbGeAlD
Topiramate—GRIA1—midbrain—attention deficit hyperactivity disorder	0.00392	0.00835	CbGeAlD
Topiramate—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00335	0.00714	CbGeAlD
Topiramate—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00335	0.00714	CbGeAlD
Topiramate—GRIA1—nervous system—attention deficit hyperactivity disorder	0.00322	0.00686	CbGeAlD
Topiramate—CA1—forebrain—attention deficit hyperactivity disorder	0.00315	0.00671	CbGeAlD
Topiramate—CA7—cerebellum—attention deficit hyperactivity disorder	0.00313	0.00667	CbGeAlD
Topiramate—GRIA2—midbrain—attention deficit hyperactivity disorder	0.00311	0.00663	CbGeAlD
Topiramate—GRIA1—central nervous system—attention deficit hyperactivity disorder	0.0031	0.00661	CbGeAlD
Topiramate—GRIA1—cerebellum—attention deficit hyperactivity disorder	0.00303	0.00646	CbGeAlD
Topiramate—CA5B—cardiovascular system—attention deficit hyperactivity disorder	0.00302	0.00643	CbGeAlD
Topiramate—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00296	0.00631	CbGeAlD
Topiramate—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.00292	0.00623	CbGeAlD
Topiramate—SCN1A—midbrain—attention deficit hyperactivity disorder	0.00284	0.00605	CbGeAlD
Topiramate—GRIK2—midbrain—attention deficit hyperactivity disorder	0.00281	0.00599	CbGeAlD
Topiramate—CA9—cerebellum—attention deficit hyperactivity disorder	0.00275	0.00585	CbGeAlD
Topiramate—CA1—cardiovascular system—attention deficit hyperactivity disorder	0.00266	0.00568	CbGeAlD
Topiramate—GRIA2—nervous system—attention deficit hyperactivity disorder	0.00256	0.00545	CbGeAlD
Topiramate—CA7—brain—attention deficit hyperactivity disorder	0.00254	0.00541	CbGeAlD
Topiramate—CA4—forebrain—attention deficit hyperactivity disorder	0.00246	0.00525	CbGeAlD
Topiramate—GRIA2—central nervous system—attention deficit hyperactivity disorder	0.00246	0.00525	CbGeAlD
Topiramate—GRIA1—brain—attention deficit hyperactivity disorder	0.00246	0.00524	CbGeAlD
Topiramate—GRIA2—cerebellum—attention deficit hyperactivity disorder	0.00241	0.00513	CbGeAlD
Topiramate—SCN1A—nervous system—attention deficit hyperactivity disorder	0.00233	0.00497	CbGeAlD
Topiramate—GRIK2—nervous system—attention deficit hyperactivity disorder	0.00231	0.00492	CbGeAlD
Topiramate—SCN1A—central nervous system—attention deficit hyperactivity disorder	0.00225	0.00479	CbGeAlD
Topiramate—GRIK2—central nervous system—attention deficit hyperactivity disorder	0.00222	0.00474	CbGeAlD
Topiramate—GABRB2—midbrain—attention deficit hyperactivity disorder	0.00221	0.00472	CbGeAlD
Topiramate—GABRG2—midbrain—attention deficit hyperactivity disorder	0.00221	0.00472	CbGeAlD
Topiramate—SCN1A—cerebellum—attention deficit hyperactivity disorder	0.0022	0.00468	CbGeAlD
Topiramate—GRIK2—cerebellum—attention deficit hyperactivity disorder	0.00217	0.00463	CbGeAlD
Topiramate—CA12—nervous system—attention deficit hyperactivity disorder	0.00216	0.0046	CbGeAlD
Topiramate—CA4—cardiovascular system—attention deficit hyperactivity disorder	0.00208	0.00444	CbGeAlD
Topiramate—CA12—central nervous system—attention deficit hyperactivity disorder	0.00208	0.00443	CbGeAlD
Topiramate—CA2—forebrain—attention deficit hyperactivity disorder	0.00204	0.00435	CbGeAlD
Topiramate—GRIA2—brain—attention deficit hyperactivity disorder	0.00195	0.00417	CbGeAlD
Topiramate—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00195	0.00416	CbGeAlD
Topiramate—CA5B—nervous system—attention deficit hyperactivity disorder	0.00194	0.00413	CbGeAlD
Topiramate—SCN5A—nervous system—attention deficit hyperactivity disorder	0.00188	0.004	CbGeAlD
Topiramate—CA5B—central nervous system—attention deficit hyperactivity disorder	0.00186	0.00397	CbGeAlD
Topiramate—GABRB2—nervous system—attention deficit hyperactivity disorder	0.00182	0.00388	CbGeAlD
Topiramate—GABRG2—nervous system—attention deficit hyperactivity disorder	0.00182	0.00388	CbGeAlD
Topiramate—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.00181	0.00385	CbGeAlD
Topiramate—SCN1A—brain—attention deficit hyperactivity disorder	0.00178	0.0038	CbGeAlD
Topiramate—GRIK2—brain—attention deficit hyperactivity disorder	0.00177	0.00376	CbGeAlD
Topiramate—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.00175	0.00373	CbGeAlD
Topiramate—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.00175	0.00373	CbGeAlD
Topiramate—CA2—cardiovascular system—attention deficit hyperactivity disorder	0.00173	0.00368	CbGeAlD
Topiramate—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.00171	0.00365	CbGeAlD
Topiramate—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.00171	0.00365	CbGeAlD
Topiramate—CA1—nervous system—attention deficit hyperactivity disorder	0.00171	0.00365	CbGeAlD
Topiramate—CA12—brain—attention deficit hyperactivity disorder	0.00165	0.00352	CbGeAlD
Topiramate—CA1—central nervous system—attention deficit hyperactivity disorder	0.00165	0.00351	CbGeAlD
Topiramate—CA4—midbrain—attention deficit hyperactivity disorder	0.00163	0.00347	CbGeAlD
Topiramate—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00161	0.00342	CbGeAlD
Topiramate—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00155	0.0033	CbGeAlD
Topiramate—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00151	0.00322	CbGeAlD
Topiramate—CA5B—brain—attention deficit hyperactivity disorder	0.00148	0.00315	CbGeAlD
Topiramate—SCN5A—brain—attention deficit hyperactivity disorder	0.00143	0.00306	CbGeAlD
Topiramate—GABRB2—brain—attention deficit hyperactivity disorder	0.00139	0.00296	CbGeAlD
Topiramate—GABRG2—brain—attention deficit hyperactivity disorder	0.00139	0.00296	CbGeAlD
Topiramate—CA2—midbrain—attention deficit hyperactivity disorder	0.00135	0.00287	CbGeAlD
Topiramate—CA4—nervous system—attention deficit hyperactivity disorder	0.00134	0.00285	CbGeAlD
Topiramate—CA1—brain—attention deficit hyperactivity disorder	0.00131	0.00279	CbGeAlD
Topiramate—CA4—central nervous system—attention deficit hyperactivity disorder	0.00129	0.00274	CbGeAlD
Topiramate—CA4—cerebellum—attention deficit hyperactivity disorder	0.00126	0.00268	CbGeAlD
Topiramate—GABRA1—brain—attention deficit hyperactivity disorder	0.00123	0.00262	CbGeAlD
Topiramate—GRIA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00115	0.00216	CbGpPWpGaD
Topiramate—GABRA1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00111	0.0021	CbGpPWpGaD
Topiramate—CA2—nervous system—attention deficit hyperactivity disorder	0.00111	0.00236	CbGeAlD
Topiramate—GABRG2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00108	0.00203	CbGpPWpGaD
Topiramate—CA2—central nervous system—attention deficit hyperactivity disorder	0.00107	0.00227	CbGeAlD
Topiramate—GRIK2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00105	0.00197	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00104	0.00197	CbGpPWpGaD
Topiramate—CA2—cerebellum—attention deficit hyperactivity disorder	0.00104	0.00222	CbGeAlD
Topiramate—CA4—brain—attention deficit hyperactivity disorder	0.00102	0.00218	CbGeAlD
Topiramate—SCN1A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.001	0.00189	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000986	0.00186	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00094	0.00177	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000917	0.00173	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000916	0.00173	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000901	0.0017	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000901	0.0017	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000891	0.00168	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000888	0.00167	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000882	0.00166	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000878	0.00165	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000865	0.00163	CbGpPWpGaD
Topiramate—CA2—brain—attention deficit hyperactivity disorder	0.000847	0.00181	CbGeAlD
Topiramate—GRIK2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000838	0.00158	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000824	0.00155	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000817	0.00154	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000803	0.00151	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000802	0.00151	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000766	0.00144	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000755	0.00142	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000747	0.00141	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00072	0.00136	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.000715	0.00135	CbGpPWpGaD
Topiramate—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000715	0.00152	CbGeAlD
Topiramate—SCN5A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000712	0.00134	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000712	0.00134	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.000706	0.00133	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.000705	0.00133	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000702	0.00132	CbGpPWpGaD
Topiramate—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000697	0.00131	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000694	0.00131	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000691	0.0013	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00069	0.0013	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000689	0.0013	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000689	0.0013	CbGpPWpGaD
Topiramate—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000688	0.00147	CbGeAlD
Topiramate—SCN1A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.000646	0.00122	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000642	0.00121	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000641	0.00121	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000635	0.0012	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000631	0.00119	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00063	0.00119	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000626	0.00118	CbGpPWpGaD
Topiramate—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000619	0.00117	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000614	0.00116	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000605	0.00114	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000602	0.00113	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000587	0.00111	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000572	0.00108	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000571	0.00108	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000557	0.00105	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000551	0.00104	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000551	0.00104	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000536	0.00101	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000532	0.001	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000528	0.000995	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000528	0.000995	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.000523	0.000985	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000518	0.000975	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000517	0.000974	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000508	0.000957	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000505	0.000951	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000504	0.00095	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.000503	0.000947	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.000497	0.000935	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000491	0.000925	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000487	0.000917	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000486	0.000915	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000485	0.000913	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000483	0.00091	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000482	0.000908	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000481	0.000907	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000481	0.000907	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000474	0.000892	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000469	0.000884	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000469	0.000884	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000465	0.000875	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000461	0.000869	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000461	0.000868	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.000454	0.000856	CbGpPWpGaD
Topiramate—CA6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000443	0.000835	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000443	0.000835	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000443	0.000835	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00044	0.000829	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000438	0.000824	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000437	0.000823	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000429	0.000808	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000422	0.000795	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000414	0.00078	CbGpPWpGaD
Topiramate—CA7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000414	0.000779	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000414	0.000779	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000406	0.000765	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000397	0.000747	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000392	0.000739	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000387	0.00073	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000385	0.000725	CbGpPWpGaD
Topiramate—CA12—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000383	0.000722	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000372	0.000701	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00037	0.000696	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000369	0.000695	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000369	0.000695	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000365	0.000687	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000363	0.000683	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000362	0.000682	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000354	0.000668	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000353	0.000665	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000343	0.000646	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000341	0.000642	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000337	0.000635	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000334	0.000628	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000331	0.000624	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000329	0.000619	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000324	0.000611	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000317	0.000597	CbGpPWpGaD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000316	0.000595	CbGpPWpGaD
Topiramate—CA6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000306	0.000576	CbGpPWpGaD
Topiramate—CA5A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000306	0.000576	CbGpPWpGaD
Topiramate—CA6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000306	0.000576	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000306	0.000576	CbGpPWpGaD
Topiramate—CA4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000306	0.000576	CbGpPWpGaD
Topiramate—CA5A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000301	0.000567	CbGpPWpGaD
Topiramate—CA6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000301	0.000567	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000301	0.000566	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000295	0.000555	CbGpPWpGaD
Topiramate—CA2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000293	0.000552	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000292	0.000549	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00029	0.000545	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000288	0.000542	CbGpPWpGaD
Topiramate—CA7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000286	0.000538	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000286	0.000538	CbGpPWpGaD
Topiramate—CA7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000286	0.000538	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000286	0.000538	CbGpPWpGaD
Topiramate—CA1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000281	0.000529	CbGpPWpGaD
Topiramate—CA7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000281	0.000529	CbGpPWpGaD
Topiramate—CA5B—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000281	0.000529	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00028	0.000527	CbGpPWpGaD
Topiramate—CA6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00028	0.000527	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000279	0.000526	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000278	0.000523	CbGpPWpGaD
Topiramate—CA12—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000265	0.000498	CbGpPWpGaD
Topiramate—CA12—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000265	0.000498	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000263	0.000495	CbGpPWpGaD
Topiramate—CA7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000261	0.000492	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000261	0.000492	CbGpPWpGaD
Topiramate—CA12—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00026	0.00049	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000256	0.000482	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000254	0.000478	CbGpPWpGaD
Topiramate—CA9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000247	0.000465	CbGpPWpGaD
Topiramate—CA6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000245	0.000461	CbGpPWpGaD
Topiramate—CA5A—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000245	0.000461	CbGpPWpGaD
Topiramate—CA12—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000242	0.000456	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000233	0.000438	CbGpPWpGaD
Topiramate—CA6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000233	0.000438	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000232	0.000436	CbGpPWpGaD
Topiramate—CA7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000228	0.00043	CbGpPWpGaD
Topiramate—CA5B—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000228	0.00043	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000223	0.000421	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000222	0.000418	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000217	0.000409	CbGpPWpGaD
Topiramate—CA7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000217	0.000409	CbGpPWpGaD
Topiramate—CA12—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000211	0.000398	CbGpPWpGaD
Topiramate—CA4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000211	0.000397	CbGpPWpGaD
Topiramate—CA4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000211	0.000397	CbGpPWpGaD
Topiramate—CA4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000208	0.000391	CbGpPWpGaD
Topiramate—CA2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000202	0.000381	CbGpPWpGaD
Topiramate—CA2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000202	0.000381	CbGpPWpGaD
Topiramate—CA12—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000201	0.000379	CbGpPWpGaD
Topiramate—CA2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000199	0.000375	CbGpPWpGaD
Topiramate—CA1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000194	0.000365	CbGpPWpGaD
Topiramate—CA1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000194	0.000365	CbGpPWpGaD
Topiramate—CA4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000193	0.000363	CbGpPWpGaD
Topiramate—CA1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000191	0.000359	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00019	0.000358	CbGpPWpGaD
Topiramate—CA6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000185	0.000349	CbGpPWpGaD
Topiramate—CA5A—Metabolism—COMT—attention deficit hyperactivity disorder	0.000185	0.000349	CbGpPWpGaD
Topiramate—CA2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000185	0.000348	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000184	0.000347	CbGpPWpGaD
Topiramate—CA6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000184	0.000347	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000184	0.000346	CbGpPWpGaD
Topiramate—CA1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000177	0.000334	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000177	0.000333	CbGpPWpGaD
Topiramate—CA7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000173	0.000326	CbGpPWpGaD
Topiramate—CA5B—Metabolism—COMT—attention deficit hyperactivity disorder	0.000173	0.000326	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000172	0.000324	CbGpPWpGaD
Topiramate—CA7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000172	0.000324	CbGpPWpGaD
Topiramate—CA9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00017	0.000321	CbGpPWpGaD
Topiramate—CA9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00017	0.000321	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000169	0.000318	CbGpPWpGaD
Topiramate—CA4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000169	0.000318	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000168	0.000316	CbGpPWpGaD
Topiramate—CA9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000168	0.000316	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000167	0.000314	CbGpPWpGaD
Topiramate—CA2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000162	0.000305	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000162	0.000304	CbGpPWpGaD
Topiramate—CA4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000161	0.000302	CbGpPWpGaD
Topiramate—CA12—Metabolism—COMT—attention deficit hyperactivity disorder	0.00016	0.000302	CbGpPWpGaD
Topiramate—CA12—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000159	0.0003	CbGpPWpGaD
Topiramate—CA9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000156	0.000294	CbGpPWpGaD
Topiramate—CA1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000155	0.000292	CbGpPWpGaD
Topiramate—CA2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000154	0.00029	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000153	0.000287	CbGpPWpGaD
Topiramate—CA1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.000278	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000141	0.000266	CbGpPWpGaD
Topiramate—CA9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000136	0.000257	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000131	0.000247	CbGpPWpGaD
Topiramate—CA9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00013	0.000244	CbGpPWpGaD
Topiramate—CA4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000128	0.000241	CbGpPWpGaD
Topiramate—CA4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000127	0.000239	CbGpPWpGaD
Topiramate—CA2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000123	0.000231	CbGpPWpGaD
Topiramate—CA2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000122	0.000229	CbGpPWpGaD
Topiramate—CA1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000117	0.000221	CbGpPWpGaD
Topiramate—CA1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000117	0.00022	CbGpPWpGaD
Topiramate—CA9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000103	0.000195	CbGpPWpGaD
Topiramate—CA9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000103	0.000193	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000102	0.000192	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000101	0.00019	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0001	0.000189	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	9.21e-05	0.000173	CbGpPWpGaD
Topiramate—CA5A—Metabolism—EP300—attention deficit hyperactivity disorder	7.95e-05	0.00015	CbGpPWpGaD
Topiramate—CA6—Metabolism—EP300—attention deficit hyperactivity disorder	7.95e-05	0.00015	CbGpPWpGaD
Topiramate—CA5B—Metabolism—EP300—attention deficit hyperactivity disorder	7.42e-05	0.00014	CbGpPWpGaD
Topiramate—CA7—Metabolism—EP300—attention deficit hyperactivity disorder	7.42e-05	0.00014	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.91e-05	0.00013	CbGpPWpGaD
Topiramate—CA12—Metabolism—EP300—attention deficit hyperactivity disorder	6.87e-05	0.000129	CbGpPWpGaD
Topiramate—CA4—Metabolism—EP300—attention deficit hyperactivity disorder	5.48e-05	0.000103	CbGpPWpGaD
Topiramate—CA2—Metabolism—EP300—attention deficit hyperactivity disorder	5.26e-05	9.9e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—EP300—attention deficit hyperactivity disorder	5.04e-05	9.49e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	4.77e-05	8.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.77e-05	8.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	4.7e-05	8.84e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—EP300—attention deficit hyperactivity disorder	4.43e-05	8.34e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.36e-05	8.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.16e-05	7.83e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.82e-05	7.19e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.63e-05	6.84e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	2.89e-05	5.45e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	2.87e-05	5.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	2.87e-05	5.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.87e-05	5.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	2.82e-05	5.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.78e-05	5.24e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.62e-05	4.94e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.29e-05	4.32e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.18e-05	4.11e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	1.74e-05	3.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	1.73e-05	3.25e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	1.24e-05	2.34e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	7.46e-06	1.4e-05	CbGpPWpGaD
